Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Phase Ib of L-NMMA and Pembrolizumab

Phase Ib of L-NMMA and Pembrolizumab
Conditions:   Non-Small Cell Lung Cancer;   Malignant Melanoma;   Head and Neck Squamous Cell Carcinoma;   Classical Hodgkin Lymphoma;   Urothelial Carcinoma Bladder;   DNA Repair-Deficiency Disorders
Interventions:   Drug: L-NMMA;   Drug: Pembrolizumab
Sponsor:   Jorge G. Darcourt

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 9, 2020 / by / in